Surviving COVID-19 and Battling Fibrosis: A Retrospective Cohort Study Across Three Pandemic Waves
Lung fibrosis represents a significant post-COVID-19 complication found in 42% of patients with severe forms of pneumonia at the 2-year evaluation. A significant overall decrease in the severity of lung fibrosis was registered at the 2-year evaluation compared to the 3-month evaluation. We consider that the amount of interstitial pulmonary involvement represents the optimal parameter to estimate the risk of lung fibrosis following SARS-CoV-2 pneumonia.
Authors
- Cătălin Tilişcan (ORCID: https://orcid.org/0000-0001-6994-7444)
- Mihaela Cristina Olariu (ORCID: https://orcid.org/0000-0002-3442-2338)
- Daniela Adriana Ion (ORCID: https://orcid.org/0000-0003-1031-7557)
- Victoria Aramă (ORCID: https://orcid.org/0000-0002-1657-3642)
- Mihai Lazăr (ORCID: https://orcid.org/0000-0002-1169-3653)
- Ștefan Sorin Aramă (ORCID: https://orcid.org/0000-0003-0019-934X)
- Cristina Emilia Chițu
- Ecaterina Constanța Barbu (ORCID: https://orcid.org/0000-0001-9560-6264)
- A Petre
- Mihaela Buzoianu
Institutions
- Carol Davila University of Medicine and Pharmacy (RO)
Publication Details
- Journal
- Diagnostics
- Published
- 2024-12-13
- DOI
- https://doi.org/10.3390/diagnostics14242811
- Citations
- 6
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 2.51